USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged <65.

Slides:

Advertisements

Similar presentations

UK Renal Registry 17th Annual Report Figure 5.1. Trend in one year after 90 day incident patient survival by first modality, 2003–2012 cohorts (adjusted.

Advertisements

UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.

USRDS Clinical Indicators of Renal Allograft Loss Lawrence Y.C. Agodoa, MD FACP Jon J. Snyder, MS Bertram L. Kasiske, MD Allan J. Collins, MD FACP United.

UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.

Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.

Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.

UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.

ESRD Prognosis ERA-EDTA vs. Danish Renal Registry James Heaf.

Number of Dialysis and Transplant Units by Year, Number of Units Total Dialysis Only Transplant USRDS 1999 XI-1 Year.

© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.

UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.

UK Renal Registry 17th Annual Report Figure Percentage of patients waitlisted for a kidney transplant by renal centre, prior to or within two years.

UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.

Healthy People 2010 Focus Area 4

CHAPTER 13 RENAL TRANSPLANTATION Editor: Dr. Goh Bak Leong Expert Panel: Dato’ Dr. Zaki Morad b Mohd Zaher (Chair) Dr. Goh Bak Leong (Co-Chair) Dr. Fan.

UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.

USRDS 1998 II , ,515 74,116 51,762 Period Prev. Point Prev. Incidence Deaths LFU** Counts (1000s) Year *Preliminary **Lost-to-Followup Reported.

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.

Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.

CHAPTER 13 Renal Transplantation Goh Bak Leong Fan Kin Sing Rohan Malek Bin Dato’ Dr. Johan Rosnawati Yahya S. Prasad Menon Tan Si Yen Wong Hin Seng Source:

UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients

USRDS USRDS 2002 adr Period prevalent ESRD patient, deaths, & ESRD expenditures figure 12.1.

USRDS 2000 ADR USRDS Hepatitis B vaccine & antibody among patients & unit staff figure 9.1, dialysis patients, 1997, by network.

USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.

2016 Annual Data Report, Vol 2, ESRD, Ch 13

Primary Cause of Kidney Failure in new ESRD patients at initiation, by ethnicity figure 2.1, combined.

2016 Annual Data Report, Vol 2, ESRD, Ch 5

2016 Annual Data Report, Vol 2, ESRD, Ch 8

Section 1: CKD Epidemiology

2016 Annual Data Report, Vol 2, ESRD, Ch 6

Healthy People 2010 targets & levels achieved in 2000 figure hp.1

Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014

First-year death rates by modality figure 8

UK Renal Registry 10th Annual Report 2007

Odd ratio of developing kidney failure figure 1

Patient populations by study group figure 10

UK Renal Registry 15th Annual Report

Summary of the 2013 ERA-EDTA Registry Annual Report

Volume 2: End-Stage Renal Disease Chapter 4: Hospitalization

Number of transplants, by donor type figure 8.1

Chapter 7: ESRD among Children, Adolescents, and Young Adults

Volume 2: End-Stage Renal Disease Chapter 6: Transplantation

UK Renal Registry 16th Annual Report

December 31st point prevalent counts by modality figure 3.1

UK Renal Registry 18th Annual Report

UK Renal Registry 9th Annual Report 2006

CHAPTER 5 Paediatric Renal Replacement Therapy

Figure 1.17 of the 2016 US Renal Data System Annual Data Report, Volume 2, chapter 1 showing the trends in the number of patients with incident ESRD (in.

2018 Annual Data Report Volume 3: Healthy People 2020

Risk factors in deceased-donor transplants Risk factor 1988

Volume 2: End-Stage Renal Disease Chapter 6: Transplantation

Number of dialysis & transplant units figure 10.1

CHAPTER 1 All Renal Replacement Therapy In Malaysia

UK Renal Registry 13th Annual Report

UK Renal Registry 16th Annual Report

UK Renal Registry 16th Annual Report

UK Renal Registry 14th Annual Report

New ESRD Patients and Main Sources

Cause Specific Death Rates for All Dialysis Patients

Reported ESRD Period and Point Prevalence,

UK Renal Registry 15th Annual Report

UK Renal Registry 14th Annual Report

UK Renal Registry 16th Annual Report

Lynda Anne Szczech, Ira L. Lazar Kidney International

UK Renal Registry 10th Annual Report 2007

Worldwide incidence of ESRD figure 12.1, per million population

Number of Donors in Australia

Presentation transcript:

USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged <65

USRDS 2000 ADR USRDS Living donor donations by gender & race figure 7.2, patients aged <65

USRDS 2000 ADR USRDS Cadaveric donations figure 7.3, per million population, patients aged <65, , by HSA Per million population

USRDS 2000 ADR USRDS Living donor donations by gender & race figure 7.4, per million population, patients <65 years old, by HSA Per million population

USRDS 2000 ADR USRDS Renal transplants by donor source figure 7.5, all transplants

USRDS 2000 ADR USRDS First transplant counts by age & gender figure 7.6, 1998

USRDS 2000 ADR USRDS First transplant rates by age & gender figure 7.7, 1998

USRDS 2000 ADR USRDS Median yearly transplants per center figure 7.8

USRDS 2000 ADR USRDS First transplant counts by race & gender figure 7.9

USRDS 2000 ADR USRDS First transplant rates by race & gender figure 7.10

USRDS 2000 ADR USRDS Trends in transplant rates by age group & gender: first cadaver transplants figure 7.11, transplants per 100 dialysis patient years

USRDS 2000 ADR USRDS Trends in transplant rates by age group & gender: repeat cadaver transplants figure 7.11, transplants per 100 dialysis patient years

USRDS 2000 ADR USRDS Trends in transplant rates by age group & gender: living donor transplants figure 7.11, transplants per 100 dialysis patient years

USRDS 2000 ADR USRDS Trends in transplant rates by race & gender: first cadaver transplants figure 7.12, transplants per 100 dialysis patient years

USRDS 2000 ADR USRDS Trends in transplant rates by race & gender: repeat cadaver transplants figure 7.12, transplants per 100 dialysis patient years

USRDS 2000 ADR USRDS Trends in transplant rates by race & gender: living donor transplants figure 7.12, transplants per 100 dialysis patient years

USRDS 2000 ADR USRDS Annual rate of graft loss figure 7.13, adjusted for age, gender, race, & primary diagnosis

USRDS 2000 ADR USRDS Projected graft half-life figure 7.14, first cadaveric transplant, adjusted for age, gender, race, & primary diagnosis

USRDS 2000 ADR USRDS Projected graft half-life figure 7.15, first living donor transplant, adjusted for age, gender, race, & primary diagnosis

USRDS 2000 ADR USRDS First-year graft survival rates figure 7.16, adjusted for age, gender, & primary diagnosis, standardized to 1996

USRDS 2000 ADR USRDS Second-year graft survival rates figure 7.16, adjusted for age, gender, & primary diagnosis, standardized to 1996

USRDS 2000 ADR USRDS Fifth-year graft survival rates figure 7.16, adjusted for age, gender, & primary diagnosis, standardized to 1996

USRDS 2000 ADR USRDS Tenth-year graft survival rates figure 7.16, adjusted for age, gender, & primary diagnosis, standardized to 1996

USRDS 2000 ADR USRDS First-year graft survival (%): Cadaveric donor, figure 7.17, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS First-year graft survival (%): Living donor, figure 7.17, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS Second-year graft survival (%): Cadaveric donor, figure 7.17, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS Second-year graft survival (%): Living donor, figure 7.17, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS Fifth-year graft survival (%): Cadaveric donor, figure 7.17, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS Fifth-year graft survival (%): Living donor, figure 7.17, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS First-year patient survival rates figure 7.18, adjusted for age, gender, & primary diagnosis, standardized to 1996

USRDS 2000 ADR USRDS Second-year patient survival rates figure 7.18, adjusted for age, gender, & primary diagnosis, standardized to 1996

USRDS 2000 ADR USRDS Fifth-year patient survival rates figure 7.18, adjusted for age, gender, & primary diagnosis, standardized to 1996

USRDS 2000 ADR USRDS Tenth-year patient survival rates figure 7.18, adjusted for age, gender, & primary diagnosis, standardized to 1996

USRDS 2000 ADR USRDS First-year patient survival (%): Cadaveric donor, figure 7.19, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS First-year patient survival (%): Living donor, figure 7.19, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS Second-year patient survival (%): Cadaveric donor, figure 7.18, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS Second-year patient survival (%): Living donor, figure 7.19, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS Fifth-year patient survival (%): Cadaveric donor, figure 7.19, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS Fifth-year patient survival (%): Living donor, figure 7.19, unadjusted, by state Percent of patients

USRDS 2000 ADR USRDS Wait-listed patients by age figure 7.20

USRDS 2000 ADR USRDS Wait-listed patients by gender figure 7.21

USRDS 2000 ADR USRDS Wait-listed patients by race figure 7.22